Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

3.24
Delayed Data
As of May 03
 -0.19 / -5.54%
Today’s Change
1.63
Today|||52-Week Range
16.83
-68.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues6.8M25.8M11.0M4.6M
 
 
 
 
 
Cost of Goods Sold30.0K393.0K1.3M6.5K
 
 
 
 
 
Depreciation And Amortization45.0K49.0K43.0K43.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.8M25.4M9.6M4.6M
 
 
 
 
 
General Expenses21.2M20.1M22.8M21.7M
 
 
 
 
 
Research And Development17.1M16.5M20.1M19.0M
 
 
 
 
 
Total Operating Expenses21.3M20.5M24.1M21.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.4M5.3M-13.2M-17.2M
 
 
 
 
 
Extraordinary Credit464.0K749.0K0.00229.0K
 
 
 
 
Extraordinary Charge--0.00-452.0K0.00
 
 
Interest Expense On Debt1.3M1.3M1.2M1.3M
 
 
 
 
 
Other Expenses0.000.00100.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.2M4.9M-14.6M-18.1M
 
 
 
 
 
Net Income-15.2M4.9M-14.6M-18.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS72.3M72.6M73.3M73.3M
 
 
 
 
 
Shares To Calculate EPS Diluted72.3M76.8M73.3M73.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21$0.06-$0.20-$0.25
 
 
 
 
 
EPS Diluted-$0.21$0.06-$0.20-$0.25